Fulgent Genetics (FLGT) Change in Cash (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Change in Cash data on file, last reported at -$26.8 million in Q1 2026.

• Quarterly Change in Cash fell 320.76% year-over-year to -$26.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$43.9 million (down 444.47% YoY) and the FY2025 annual result came in at -$5.0 million, up 88.27% from the prior year.
• Change in Cash advanced to -$26.8 million in Q1 2026 per FLGT's latest filing, from -$67.4 million in the prior quarter.
• The five-year high for Change in Cash was $188.2 million in Q1 2022, with the low at -$214.3 million in Q2 2022.
• Average Change in Cash over 5 years is -$8.3 million, with a median of -$2.9 million recorded in 2024.
• The widest YoY moves for Change in Cash: up 529.2% in 2025, down 2227.4% in 2025.
• Fulgent Genetics' Change in Cash stood at -$89.3 million in 2022, then soared by 115.01% to $13.4 million in 2023, then plunged by 121.63% to -$2.9 million in 2024, then slumped by 2227.4% to -$67.4 million in 2025, then jumped by 60.27% to -$26.8 million in 2026.
• Business Quant data shows FLGT's Change in Cash at -$26.8 million in Q1 2026, -$67.4 million in Q4 2025, and $29.8 million in Q3 2025.